Stephen Davis

Affiliations

  • Ceo at Acadia Pharmaceuticals Inc (ACAD), 2024-08-20
  • Director at Bellicum Pharmaceuticals Inc (BLCM), 2023-01-05
  • Director at Heron Therapeutics Inc. (HRTX), 2022-12-20
  • Director at Synageva Biopharma Corp (GEVA), 2015-06-23
  • Director at Furiex Pharmaceuticals Inc. (FURX), 2014-07-07
  • Evp & Coo at Ardea Biosciences Inc. (RDEA), 2012-06-20
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ACAD $15.28 31,747 $485,094.16 186,555 2024-08-19 Filing
ACAD $16.94 11,427 $193,573.38 155,231 2024-05-02 Filing
ACAD $17.87 17,716 $316,584.92 144,267 2024-04-08 Filing
ACAD $17.87 8,858 $158,292.46 161,983 2024-04-08 Filing
ACAD $17.90 17,714 $317,080.60 118,842 2024-03-27 Filing